JONES EVAN/ FA
SEC CIK 1020741 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VCYT | VERACYTE, INC. | Dir | 34.6K | — | $6.29M | 29 | 2022-01-11 | 2026-06-11 |
Most active insiders at VCYT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Stapley Marc | CEO, Dir | — | $8.92M |
| 2 | JONES EVAN/ FA | Dir | — | $2.00M |
| 3 | Chambers Rebecca | CFO | — | $1.91M |
| 4 | McGuire Annie | SVP, GC | — | $1.80M |
| 5 | Wygant Jonathan | VP, CAO | — | $1.54M |
| 6 | EASTHAM KARIN | Dir | — | $1.49M |
| 7 | Febbo Phillip G. | Chief Scientific, Med Off | — | $1.35M |
| 8 | Leite John | Gbl Chief Commercial Off | — | $1.34M |
| 9 | EPSTEIN ROBERT S | Dir | — | $1.19M |
| 10 | Holstein Jens | Dir | — | $628.3K |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-15 16:56 | 2026-06-11 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +5,272 | 34.6K | +18% | $0 | |
| 2025-11-26 | 2025-11-25 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $50.25 | -1,106 | 29.4K | -4% | -$55.6K | |
| DM | 2025-11-07 | 2025-11-05 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $6.94 | +30.0K | 53.7K | +127% | +$208.2K |
| DM | 2025-11-07 | 2025-11-05 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $45.06 | -43.2K | 73.3K | -37% | -$1.95M |
| 2025-06-23 | 2025-06-18 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +9,321 | 43.7K | +27% | $0 | |
| I | 2024-09-23 | 2024-09-19 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $35.23 | -5,173 | 0 | -100% | -$182.2K |
| DM | 2024-08-14 | 2024-08-12+ | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $32.20 | -20.6K | 46.3K | -31% | -$661.8K |
| DMI | 2024-08-14 | 2024-08-12+ | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $32.20 | -27.3K | 32.4K | -46% | -$878.7K |
| D | 2024-08-14 | 2024-08-13 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +8,486 | 54.8K | +18% | +$88.3K |
| DI | 2024-08-13 | 2024-08-09 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $30.03 | -746 | 32.5K | -2% | -$22.4K |
| D | 2024-08-13 | 2024-08-09 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +300 | 47.4K | +0.6% | +$3,123 |
| D | 2024-08-13 | 2024-08-09 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $30.03 | -1,032 | 46.4K | -2% | -$31.0K |
| AI | 2024-08-13 | 2024-08-07 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.32 | -1,965 | 33.2K | -6% | -$59.6K |
| A | 2024-08-13 | 2024-08-07 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.32 | -3,143 | 47.1K | -6% | -$95.3K |
| D | 2024-08-09 | 2024-08-07 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $10.41 | +1,214 | 50.3K | +2% | +$12.6K |
| D | 2024-08-09 | 2024-08-07 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $30.32 | -5,108 | 45.2K | -10% | -$154.9K |
| 2024-06-17 | 2024-06-13 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +11.5K | 49.1K | +31% | $0 | |
| D | 2024-03-05 | 2024-03-01 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $13.19 | +10.0K | 47.6K | +27% | +$131.9K |
| D | 2024-03-05 | 2024-03-01 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale+OE | $24.36 | -10.0K | 37.6K | -21% | -$243.6K |
| 2023-07-24 | 2023-07-19 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.14 | -838 | 37.6K | -2% | -$25.3K | |
| I | 2023-07-24 | 2023-07-19 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.17 | -3,090 | 35.2K | -8% | -$93.2K |
| MI | 2023-07-19 | 2023-07-17+ | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.10 | -31.4K | 45.7K | -41% | -$944.8K |
| M | 2023-07-19 | 2023-07-17+ | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.08 | -21.4K | 40.8K | -34% | -$644.3K |
| 2023-06-13 | 2023-06-09 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +9,674 | 59.9K | +19% | $0 | |
| 2022-12-16 | 2022-12-14 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.13 | -600 | 50.2K | -1% | -$18.1K | |
| M | 2022-12-15 | 2022-12-13 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.72 | -1,667 | 51.1K | -3% | -$51.2K |
| M | 2022-11-15 | 2022-11-11 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | S - Sale | $30.22 | -6,000 | 52.6K | -10% | -$181.3K |
| 2022-06-16 | 2022-06-16 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | A - Grant | $0.00 | +14.7K | 58.5K | +34% | $0 | |
| D | 2022-01-13 | 2022-01-11 | VCYT | VERACYTE, INC. | JONES EVAN/ FA | Dir | M - OptEx | $4.00 | +5,000 | 43.7K | +13% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations